Clinical Trials Logo

Filter by:
NCT ID: NCT05939323 Recruiting - Adolescent Clinical Trials

Correlation Study of Family Communication Disorders and Negative Network Use Behavior Among Adolescents

Start date: July 1, 2023
Phase:
Study type: Observational

The entry point of this project is the social background of the post-epidemic era, with teenagers and parents as the research object, aims to explore the relationship between family communication disorders and adolescent negative network use behavior in the post-epidemic era. This project intends to investigate whether there are family communication disorders and negative Internet use behaviors among 14-25 year old teenagers by issuing questionnaires (sample size: 140). In order to conclude whether there is some connection between family communication disorder and adolescent negative network use behavior.

NCT ID: NCT05939232 Recruiting - Clinical trials for X-linked Adrenoleukodystrophy

Registry of X-linked Adrenoleukodystrophy

Start date: July 20, 2023
Phase:
Study type: Observational [Patient Registry]

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

NCT ID: NCT05939219 Recruiting - Healthy Volunteers Clinical Trials

Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to evaluate the consistency of the 15-valent pneumococcal conjugate vaccine in three batches of the 3-month-old population, as well as the immunogenicity and safety of vaccination in the 7-5-year-old population

NCT ID: NCT05939193 Recruiting - Acute Kidney Injury Clinical Trials

Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC

Start date: July 24, 2023
Phase: N/A
Study type: Interventional

Acute renal injury (AKI) is a common complication after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), and is associated with worse outcomes. Available evidences show that maintaining intraoperative urine output ≥ 200 ml/h by fluid and furosemide administration may reduce the incidence of AKI in patients undergoing cardiopulmonary bypass. The investigators hypothesize that, for patients undergoing CRS-HIPEC, intraoperative urine-volume guided hydration may also reduce the incidence of postoperative AKI.

NCT ID: NCT05939180 Recruiting - Clinical trials for Acute Myeloid Leukemia

VA vs DA for Newly Diagnosed Hig-risk AML

Start date: April 1, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

This is an open-label, multicenter, phase 2b, randomized study aiming to compare the efficacy and safety of venetoclax plus azacytidine Versus daunorubicin plus cytarabine (conventional 7+3 regimen) in adult acute myeloid leukemia (AML) patients with adverse risk featuress. Participants will be 1:1 randomly assigned to the VA and DA groups. Once remission was achieved, consolidated chemotherapy will be performed and allogeneic hematopoietic stem cell transplantation is strongly recommended. After completion of the study intervention, participants will be followed-up every 1 to 2 months for up to 2 years.

NCT ID: NCT05939167 Recruiting - AIDS Clinical Trials

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

Start date: December 10, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for AIDS patients at late stage.

NCT ID: NCT05939063 Recruiting - Clinical trials for Left-sided Pancreatic Cancer

LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.

NCT ID: NCT05938907 Recruiting - Bone Substitute Clinical Trials

Effect of Concentrated Growth Factors on Healing of Apicomarginal Defects: a Prospective Study

Start date: June 15, 2023
Phase: N/A
Study type: Interventional

The persistent and chronic apical periodontitis has caused great difficulties for clinical physicians. Ensuring rapid and successful healing of the extensively damaged periapical region is a pressing issue that needs to be addressed. The treatment options include traditional apical surgery, simultaneous placement of bone powder and membrane after apical surgery, and simultaneous placement of sticky bone (bone powder mixed with concentrated growth factors gel) and membrane. However, high-quality evidence regarding these various treatment options is scarce. The purpose of this study is to compare the advantages and disadvantages of each treatment option, in order to guide clinical physicians in the application of apical surgery.

NCT ID: NCT05938881 Recruiting - Clinical trials for Pelvic Organ Prolapse

Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study

Start date: June 29, 2023
Phase:
Study type: Observational

The original RCT trial is designed to compare self-tailored titanium-coated polypropylene mesh procedure with mesh-kit in the treatment of POP stage III-IV in terms of efficacy, safety and cost-effective at 1-year follow-up. This study will follow women in the original RCT study for up to 10 years from the time of the surgery to compare success and complication rates in the two groups. Recruitment into this study is open only to women that already participated in previous RCT, no new treatment interventions will be given. Recruitment into the previous RCT is closed. Women will be strongly encouraged to participate in annual examinations and annual telephone surveys but may participate in only one of these study parts if needed.

NCT ID: NCT05938374 Recruiting - Soft Tissue Sarcoma Clinical Trials

Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma

Start date: May 1, 2023
Phase: Phase 2
Study type: Interventional

To investigate the safety and efficacy of preoperative moderately fractionated IMRT and concurrent Fluzoparib Hydrochloride for primary truncal or extremity soft tissue sarcoma.